Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Clinical trial NCT06462092 · RECRUITING
Trial details
- NCT number
- NCT06462092
- Sponsor
- Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-01-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.